Our in vivo distribution studies using 89Zr-10G1 and 89Zr-3F8 showed that the antibodies were able to specifically colocalize and accumulate in the xenograft tumour expressing RON with little cross reactivity to the RON knockout tumour. This evidence concerns the gene MST1R and neoplasm.